Uveitis in children

Et, Cunningham

doi:10.1076/ocii.8.4.251.6459

Cited by 191 publications

(135 citation statements)

References 42 publications

Supporting

Mentioning

115

Contrasting

Unclassified

Order By: Relevance

“…1,2 Early diagnosis and appropriate therapy is critical to prevent sightthreatening complications associated with ocular inflammatory diseases. 3,4 For many years the only available option to treat these patients were systemic and topical corticosteroids, in many cases with prolonged therapy, with the guaranteed adverse effects. The efficacy and relative safety of immunomodulatory therapy (IMT) to control the ocular and possible systemic associations have been shown in the literature.…”

Section: Introductionmentioning

confidence: 99%

Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts eye research and surgery Institution experience

Giuliari

Chang

Thakuria

et al. 2010

Eye

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts eye research and surgery Institution experience

Giuliari

Chang

Thakuria

et al. 2010

Eye

View full text Add to dashboard Cite

show abstract

“…Juvenile idiopathic arthritis (JIA) describes a heterogeneous group of idiopathic arthritides occurring in children under the age of 16 years. This is the commonest disease association with anterior uveitis in childhood [13]. Though no correlation exists between disease activity in the joint and eye inflammation, an association between the mode of onset of JIA and risk of eye inflammation is well recognised.…”

Section: Classification Of Uveitismentioning

confidence: 99%

Uveitis: A Potentially Blinding Disease

Durrani¹,

Meads

Murray³

2004

Ophthalmologica

262

170

View full text Add to dashboard Cite

Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune, conditions predominantly occurring in the working age group. Although the aetiology is unknown in most cases, many patients have an associated underlying systemic disease. Central vision loss, in the form of cystoid macular oedema, is the commonest type of visual impairment. Although historical incidence and prevalence data exists, little is known about the degree of vision loss experienced, and the social and financial consequences of having temporary or permanent visual impairment in this age group. The literature is also full of uncontrolled studies and case reports of different modalities of drug therapy for uveitis. This article attempts to raise the awareness of uveitis as an important sight-threatening group of conditions by highlighting the paucity of evidence-based data on epidemiological, quality of life, socioeconomic, and therapeutic aspects.

show abstract

“…1 The so-called idiopathic form of uveitis is the most frequent in all age groups, [2][3][4][5][6][7] although there may be differences in disease presentation or course. 6,7 Other systemic diseases that may present as uveitis in children include juvenile rheumatoid arthritis (JRA), Behcet disease, sarcoidosis, tubulo-interstitial nephritis, and Kawasaki disease. 8 The aim of the present study was to evaluate the clinical course, visual outcome, and complications of pediatric uveitis.…”

mentioning

confidence: 99%